Antiplatelet therapy with blood thinners reduces mortality for angioplasty patients

Patients with acute coronary syndrome who have undergone angioplasty have a reduced risk of all-cause in-hospital mortality but an increased risk of bleeding when given glycoprotein 2b/3a inhibitors after the procedure, according to a new study.